Aqualane Clinical Research

Futó vizsgálatok

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Forrás

• Toboroz

  A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

  NCT07250750· 1/2. fázis· Forrás

• Toboroz

  A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  NCT07115329· 2. fázis· Forrás

• Toboroz

  A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  NCT06793397· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  NCT07225504· 3. fázis· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  NCT07091630· 3. fázis· Forrás

• Toboroz

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  NCT06846281· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· 2. fázis· Forrás

• Fut, nem toboroz

  Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

  NCT06869785· 3. fázis· Forrás

• Toboroz

  A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

  NCT06809400· 1. fázis· Forrás

• Fut, nem toboroz

  A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

  NCT06709014· 3. fázis· Forrás

• Fut, nem toboroz

  Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  NCT06700343· 3. fázis· Forrás

• Toboroz

  A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

  NCT06657768· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· 3. fázis· Forrás

• Toboroz

  A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

  NCT06565195· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

  NCT06335173· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

  NCT05070858· 3. fázis· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

  NCT05156281· 3. fázis· Forrás

• Toboroz

  Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  NCT04649242· 3. fázis· Forrás

• Fut, nem toboroz

  Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

  NCT03650114· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Sclerosis multiplex (SM)4 toboroz
• Alzheimer-kór2 toboroz
• Depresszió2 toboroz
• Parkinson-kór2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Migrén1 toboroz
• Myasthenia gravis1 toboroz
• Skizofrénia1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Toboroz

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· 3. fázis· Forrás

• Leállították

  Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

  NCT06304883· 3. fázis· Forrás

• Lezárult

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· 2. fázis· Forrás

• Lezárult

  Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis

  NCT06083753· 2. fázis· Forrás

• Lezárult

  A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

  NCT05637801· Forrás

• Lezárult

  GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

  NCT05189210· 2. fázis· Forrás

• Lezárult

  A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

  NCT05113771· 2. fázis· Forrás

• Lezárult

  An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

  NCT04770220· 3. fázis· Forrás

• Lezárult

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· 3. fázis· Forrás

• Lezárult

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· 3. fázis· Forrás

• Lezárult

  Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

  NCT04602390· 1. fázis· Forrás